Surmodics Pharmaceuticals Inc Birmingham, AL - 35211

Surmodics Pharmaceuticals Inc is categorized under Commercial Medical Research in Birmingham, AL and active since 2007.

Surmodics Pharmaceuticals Inc was established in 2007, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Arthur J Tipton at the company’s single location by writing to 756 Tom Martin Drive, Birmingham, Alabama AL 35211 or by phoning (205) 917-2200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Surmodics Pharmaceuticals Inc
Contact Person: Arthur J Tipton
Address: 756 Tom Martin Drive, Birmingham, Alabama 35211
Phone Number: (205) 917-2200
Website Address: surmodics.com
Annual Revenue (USD): Unknown
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Surmodics Pharmaceuticals Inc was started in 2007 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Arthur J Tipton for inquiries that concern Surmodics Pharmaceuticals Inc by calling the company number (205) 917-2200, as your correspondence is most welcome. Additionally, the physical location of the single location of Surmodics Pharmaceuticals Inc can be found at the coordinates 33.434899,-86.850388 as well as the street address 756 Tom Martin Drive in Birmingham, Alabama 35211.

For its online presence, you may visit Surmodics Pharmaceuticals Inc’s website at surmodics.com and engage with its social media outlets through on Twitter and on Facebook.